Finance

Lists
Why is ALHC up 10.15%?
Dive Deeper
ALHC:NASDAQ
Alignment Healthcare Inc
$8.14
+10.15%
(+0.75) 1D
$8.27
+1.60% (+0.13)
After hours
Closed: Nov 4, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALHC...
Open
$7.54
High
$8.24
Low
$7.45
Mkt. cap
1.70B
Avg. vol.
9.02M
Volume
5.56M
P/E ratio
62.51
52-wk high
$25.12
52-wk low
$6.01
EPS
$0.13
Beta
1.07
Shares outstanding
209.27M
No. of employees
2K
Open
$7.54
High
$8.24
Low
$7.45
Mkt. cap
1.70B
Avg. vol.
9.02M
Volume
5.56M
P/E ratio
62.51
52-wk high
$25.12
52-wk low
$6.01
EPS
$0.13
Beta
1.07
Shares outstanding
209.27M
No. of employees
2K
News stories
From web sources and news partners
About Alignment Healthcare Inc
CEOJohn Kao
Employees1.85K
Founded2013
HeadquartersOrange, California, United States
SectorHealth care provider
Industry-
Websitealignmenthealth.com
Analyst ratings
Based on 12 analysts giving stock ratings to ALHC in the past 3 months
Buy
Buy
6
Hold
6
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ALHC in the last 3 months.
Highest
Current $8.14
$17.00 (+108.85%)
Average
$10.57 (+29.85%)
Lowest
$8.00 (-1.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Maintained
$17.00
+108.8%
11/02/2026
Gary Taylor
TD Cowen
Buy
Reiterated
$10.00
+22.9%
11/02/2026
Kevin Fischbeck
Bank of America Securities
Hold
Maintained
-
-
10/30/2026
John Stansel
J.P. Morgan
Buy
Maintained
$8.00
-1.7%
10/30/2026
Jonathan Yong
UBS
Hold
Maintained
$8.00
-1.7%
10/30/2026
Unknown Analyst
Stephens
Buy
Maintained
$10.00
+22.9%
10/30/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$9.00
+10.6%
10/30/2026
Matthew Gillmor CFA
KeyBanc
Hold
Downgraded
-
-
10/30/2026
Matthew Shea
Needham
Hold
Reiterated
-
-
10/30/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
$12.00
+47.4%
10/22/2026
Ryan Langston
TD Cowen
Buy
Maintained
$12.00
+47.4%
10/12/2026
Ryan Daniels
William Blair
Hold
Downgraded
-
-
10/08/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
-
-
10/05/2026
Parker Snure
Raymond James
Buy
Maintained
$19.00
+133.4%
08/03/2026
Michael Craig Jones
Bank of America Securities
Buy
Maintained
-
-
07/31/2026
John Ransom
Raymond James
Buy
Maintained
-
-
07/09/2026
Michael Ha
Robert W. Baird
Buy
Maintained
$28.00
+244%
01/30/2026
Last report
Oct 29, 2026
Fiscal period
Q3 2026
$0.05 / $0.04
+5.91%beat
Revenue / Est. (USD)
1.36B / 1.32B
+2.88%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.01B
1.24B
1.34B
1.36B
Cost of goods sold
889.49M
1.09B
1.15B
1.22B
Cost of revenue
889.49M
1.09B
1.15B
1.22B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126.46M
121.14M
131.00M
136.37M
Operating expense
134.32M
128.98M
138.86M
144.48M
Total operating expenses
1.02B
1.22B
1.29B
1.36B
Operating income
-11.01M
15.50M
42.10M
-3.79M
Other non operating income
-72.00K
-
1.00K
-
EBT including unusual items
-14.23M
11.44M
37.83M
-8.07M
EBT excluding unusual items
-15.03M
11.44M
37.83M
-8.07M
Income tax expense
-3.23M
25.00K
1.27M
-22.00K
Effective tax rate
22.67%
0.22%
3.35%
0.27%
Other operating expenses
-
-
-
-
Net income
-11.01M
11.42M
36.56M
-8.05M
Net profit margin
-1.09%
0.92%
2.74%
-0.59%
Earnings per share
-0.00
0.12
0.25
0.05
Interest and investment income
-
-
-
-
Interest expense
-3.95M
-4.06M
-4.28M
-4.28M
Net interest expenses
-3.95M
-4.06M
-4.28M
-4.28M
Depreciation and amortization charges
7.86M
7.84M
7.85M
8.11M
EBITDA
-3.18M
23.36M
49.96M
4.32M
Gain or loss from assets sale
-
-
-1.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps